Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
O-I Glass | OI | Oct 30, 2024 | 11.55 | -7.15 |
Oak Valley Bancorp | OVLY | Oct 30, 2024 | 27.05 | -0.41 |
Oak Woods Acquisition | OAKU | Oct 30, 2024 | 11.20 | 0.00 |
Oaktree Acquisition III Life Sciences Unit | OACCU | Oct 30, 2024 | 10.00 | 0.00 |
Oaktree Capital A Pref | OAK-A | Oct 30, 2024 | 24.34 | +0.16 |
Oaktree Capital Group B Pref | OAK-B | Oct 30, 2024 | 23.43 | +0.77 |
Oaktree Specialty | OCSL | Oct 30, 2024 | 16.39 | +1.17 |
Oatly ADR | OTLY | Oct 30, 2024 | 0.80 | -2.13 |
Oblong | OBLG | Oct 30, 2024 | 3.52 | +2.62 |
Occidental Petroleum | OXY | Oct 30, 2024 | 50.17 | +0.18 |
Ocean Biomedical | OCEA | Oct 30, 2024 | 0.87 | -5.43 |
Ocean Power Technologies | OPTT | Oct 30, 2024 | 0.15 | +0.40 |
Oceaneering International | OII | Oct 30, 2024 | 24.74 | -0.04 |
OceanFirst Financial | OCFC | Oct 30, 2024 | 18.54 | +1.81 |
OceanFirst Pref | OCFCP | Oct 30, 2024 | 25.51 | +1.07 |
OceanPal | OP | Oct 30, 2024 | 1.64 | -1.20 |
Ocugen | OCGN | Oct 30, 2024 | 0.97 | +1.11 |
Ocular Therapeutix | OCUL | Oct 30, 2024 | 11.08 | -1.95 |
Oculis | OCS | Oct 30, 2024 | 17.17 | +1.18 |
Ocuphire Pharma | IRD | Oct 30, 2024 | 1.25 | 0.00 |
Ocuphire Pharma | OCUP | Oct 30, 2024 | 1.17 | 0.00 |
Oddity Tech | ODD | Oct 30, 2024 | 39.24 | -1.06 |
Odyssey Marine Exploration | OMEX | Oct 30, 2024 | 0.52 | -2.75 |
Offerpad Solutions A | OPAD | Oct 30, 2024 | 3.00 | -1.32 |
Office Properties | OPI | Oct 30, 2024 | 1.97 | +4.79 |
OFG Bancorp | OFG | Oct 30, 2024 | 40.80 | +1.24 |
OFS Capital | OFS | Oct 30, 2024 | 8.15 | +0.37 |
OFS Credit | OCCI | Oct 30, 2024 | 7.03 | +1.30 |
OFS Credit C Pref | OCCIO | Oct 30, 2024 | 24.80 | -0.60 |
OFS Credit Company Pref F | OCCIM | Oct 30, 2024 | 24.93 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.